News-Nantong Neiwa Faith Pharmaceutical Co., Ltd.

Home > News

Announcement by the National Medical Products Administration on the Application of the ICH M13A: Bioequivalence for Immediate-Release Oral Solid Dosage Forms Guidelines for International Harmonization of Technical Requirements for Registration of Pharmace

Announcement by the National Medical Products Administration on the Application of the ICH M13A: Bioequivalence for Immediate-Release Oral Solid Dosage Forms Guidelines for International Harmonization of Technical Requirements for Registration of Pharmace2026-05-25

Announcement by the National Medical Products Administration on the Issuance of the Measures for the Protection of Drug Trial Data

Announcement by the National Medical Products Administration on the Issuance of the Measures for the Protection of Drug Trial Data2026-05-25

Notice from the Center for Drug Evaluation of the National Medical Products Administration on the Release of 'Major Deficiency Situations in Pharmaceutical Research of Chemical Generic Drugs' and 'Major Deficiency Situations in Bioequivalence Studies of C

Notice from the Center for Drug Evaluation of the National Medical Products Administration on the Release of 'Major Deficiency Situations in Pharmaceutical Research of Chemical Generic Drugs' and 'Major Deficiency Situations in Bioequivalence Studies of C2026-05-25

Return to top

© 2026 Nantong Neiwa Faith Pharmaceutical Co., Ltd. All Rights Reserved.